Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Winmark (WINA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Winmark (WINA) over the last 16 years, with Q3 2025 value amounting to $39.7 million.

  • Winmark's Cash & Equivalents rose 682.26% to $39.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.7 million, marking a year-over-year increase of 682.26%. This contributed to the annual value of $12.2 million for FY2024, which is 876.92% down from last year.
  • According to the latest figures from Q3 2025, Winmark's Cash & Equivalents is $39.7 million, which was up 682.26% from $28.8 million recorded in Q2 2025.
  • In the past 5 years, Winmark's Cash & Equivalents registered a high of $40.6 million during Q3 2023, and its lowest value of $287500.0 during Q1 2022.
  • Over the past 5 years, Winmark's median Cash & Equivalents value was $21.8 million (recorded in 2025), while the average stood at $21.4 million.
  • In the last 5 years, Winmark's Cash & Equivalents crashed by 9638.81% in 2022 and then surged by 843968.7% in 2023.
  • Quarter analysis of 5 years shows Winmark's Cash & Equivalents stood at $11.4 million in 2021, then increased by 19.36% to $13.6 million in 2022, then decreased by 1.87% to $13.4 million in 2023, then decreased by 8.77% to $12.2 million in 2024, then surged by 225.97% to $39.7 million in 2025.
  • Its Cash & Equivalents stands at $39.7 million for Q3 2025, versus $28.8 million for Q2 2025 and $21.8 million for Q1 2025.